Uncategorized

Tango data add to growing momentum for pancreatic cancer drugs

A combination involving Tango’s experimental therapy appeared to boost response rates in a small clinical trial well beyond what would be expected, sparking a share surge.

Read More

Published

on

A combination involving Tango’s experimental therapy appeared to boost response rates in a small clinical trial well beyond what would be expected, sparking a share surge.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version